<DOC>
	<DOC>NCT02018731</DOC>
	<brief_summary>The purpose of the study is to compare the effects of L-citrulline and metformin and their combination therapy on muscle function and force in patients with Becker muscular dystrophy (BMD).</brief_summary>
	<brief_title>L-citrulline and Metformin in Becker's Muscular Dystrophy</brief_title>
	<detailed_description>This is a single center, not-randomized open study. The study medication consists of L-citrulline and metformin administered orally; 5g citrulline and 500mg metformin tablets will be given 3 times daily. Half of the patients will be treated with metformin during the first 6 weeks of the study. The other patients will receive initially L-citrulline for 6 weeks, before all patients will be treated with the combination therapy (metformin and L-citrulline) for another 6 week period. The study lasts 12 weeks and includes the screening visit and 3 further visits at baseline, week 6 and week 12.</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>18 years or older Molecular or immunohistochemical diagnosis of BMD ambulant at the time point of screening Participation in another therapeutic BMD study within the last 3 months Use of LArginine, LCitrulline or Metformin within the last 3 months Other chronic disease or relevant limitation of renal, liver, heart function according to discretion of investigator known hypersensitivity to Lcitrulline or metformin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Becker's Muscular dystrophy</keyword>
	<keyword>BMD</keyword>
	<keyword>Metformin</keyword>
	<keyword>L-citrulline</keyword>
</DOC>